Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05987761 · ClinicalTrials.gov registry record · NA
PRT for Adolescents With High Functioning Autism
A NA study of Autism and Child Development, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT05987761: Recruiting NA study of Autism and Child Development, sponsored by Stanford University.
NCT05987761 is a NA study of Autism and Child Development that is actively recruiting participants, run by Stanford University. The registered enrollment target is 76 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05987761, a NA study of Autism and Child Development, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify improvement in behavioral and social function and changes in the brain following Pivotal Response Treatment (PRT) for Adolescents in highly verbal adolescents with autism spectrum disorder (ASD).
Conditions Studied
Interventions
- BEHAVIORAL PRT for Adolescents
Study Locations (1)
California
- Stanford Research Park - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05987761 shows while recruiting
NCT05987761 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (58% lower).
The record links to 6 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which PRT for Adolescents is the first listed.
NCT05987761 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05987761 about?
NCT05987761 is a clinical study titled "PRT for Adolescents With High Functioning Autism". The purpose of this study is to identify improvement in behavioral and social function and changes in the brain following Pivotal Response Treatment (PRT) for Adolescents in highly verbal adolescents with autism spectrum disorder (ASD).
What is the current status of trial NCT05987761?
This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2023-09-01. Estimated completion is 2026-08-31.
What conditions does trial NCT05987761 study?
This clinical trial studies the following conditions: Autism, Child Development, Developmental Disability, Behavior, Child, Behavior, Social.
What interventions are being tested in trial NCT05987761?
The interventions under investigation include: PRT for Adolescents (BEHAVIORAL).
Who is sponsoring clinical trial NCT05987761?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05987761 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05987761's enrollment target sits among peer trials
76 49th of 104 higher than 56 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI